Showing results (1111-1120 of 1,797) with videos related to

Sort By:
Pageof 180
Mabs|December 27, 2019
Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assemblyMercè Farràs, Joan Miret, Marc Camps, et al.
Mabs|December 27, 2019
Rapid two-dimensional Protein-A size exclusion chromatography of monoclonal antibodies for titer and aggregation measurements from harvested cell culture fluid samplesZachary D Dunn, Jayesh Desai, Gabriel M Leme, et al.
Mabs|April 7, 2020
A rapid method for relative quantification of N-glycans from a therapeutic monoclonal antibody during trastuzumab biosimilar developmentZaneer Segu, Todd Stone, Claudia Berdugo, et al.
Mabs|October 12, 2020
Design of next-generation therapeutic IgG4 with improved manufacturability and bioanalytical characteristicsZhiqiang Chen, Yueming Qian, Yuanli Song, et al.
Mabs|October 30, 2020
Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodiesGwo-Yu Chuang, Mangaiarkarasi Asokan, Vera B Ivleva, et al.
Mabs|June 18, 2016
Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-lifeRalph Adams, Laura Griffin, Joanne E Compson, et al.
Mabs|October 28, 2021
Nonclinical safety evaluation, pharmacokinetics, and target engagement of Lu AF82422, a monoclonal IgG1 antibody against alpha-synuclein in development for treatment of synucleinopathiesLone Fjord-Larsen, Annemette Thougaard, Karen Malene Wegener, et al.
Mabs|November 1, 2021
Identification of a CE-SDS shoulder peak as disulfide-linked fragments from common CH2 cleavages in IgGs and IgG-like bispecific antibodiesMingyan Cao, Yang Jiao, Conner Parthemore, et al.
Mabs|July 22, 2022
TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activityHarshad S Ugamraj, Kevin Dang, Laure-Hélène Ouisse, et al.
Mabs|January 12, 2016
Incomplete target neutralization by the anti-cancer antibody rilotumumabSameer A Greenall, Timothy E Adams, Terrance G Johns
Pageof 180